VivoSeq
Other

Oxycodone

0

Pipeline Programs↗

0

Active Trials↗

9

Companies Involved↗

Oxycodone is an early-stage landscape with 0 programs across 9 companies. The most active players are Pain Therapeutics, Mundipharma Pharmaceuticals B.V., Purdue Pharma LP.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pain Therapeutics

0 programs

PreclinicalM

Mundipharma Pharmaceuticals B.V.

0 programs

PreclinicalP

Purdue Pharma LP

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalA

Acura Pharmaceuticals Inc.

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

41

clinical trials

Completed35 · 85%
Unknown status3 · 7%
Terminated2 · 5%
Withdrawn1 · 2%

Clinical Trials

Trial Activity

41 trials

Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
Completed·MMallinckrodt·Phase 1·NCT00853892·34 enrolled
Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets
Completed·MMallinckrodt·Phase 1·NCT00853320·38 enrolled
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Completed·MMundipharma Pharmaceuticals B.V.·Phase 3·NCT01167127·113 enrolled
Long-term Safety of PF-00345439 (Oxycodone)
Completed·PPain Therapeutics·Phase 3·NCT01559701·823 enrolled
Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone
Completed·PPeking University People's Hospital·Phase 4·NCT04396587·80 enrolled
Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
Completed·MMallinckrodt·Phase 1·NCT00853736·23 enrolled
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Completed·MMundipharma Pharmaceuticals B.V.·Phase 3·NCT01167699·174 enrolled
Oxycodone (10, 20 mg) in a Postoperative Dressing
Completed·PPoznan University of Medical Sciences·Phase 4·NCT06142591·20 enrolled
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
Completed·PPain Therapeutics·Phase 1·NCT02117583·34 enrolled
Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study
Completed·YYale University·Phase 1·NCT05447286·9 enrolled
Comparison of Epidural Oxycodone and Epidural Morphine
Completed·KKK Women's and Children's Hospital·Phase 3·NCT02277678·100 enrolled
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone
Completed·PPain Therapeutics·Phase 1·NCT01552850·18 enrolled
Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
Completed·MMallinckrodt·Phase 1·NCT00853216·38 enrolled
Oxycodone Pharmacokinetics in Preterm Infants
Completed·KKuopio University Hospital·N/A·NCT02564003·79 enrolled
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
Completed·PPain Therapeutics·Phase 1·NCT01552863·21 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)